The arithmetic of Ubtech Robotics’ turnaround story is striking on paper. First-half 2026 revenue hit 1.269 billion yuan, up 104 percent year on year, while net losses narrowed from 413.65 million yuan to 311.48 million yuan. Full-size humanoid sales alone reached 590.3 million yuan — a 1,445 percent jump — with 16,123 units shipped across the period. Those figures suggest a company that has cleared the treacherous passage from prototype theatre to serial production.
Yet the equity market remains conspicuously unimpressed. The stock trades at €8.89, down 1.2 percent on the day, off 9.3 percent over the past month and 38 percent lower since the start of the year. At 48 percent below January’s 52-week high of €17.00, the shares sit barely four percent above their July 30 trough. Annualised volatility of 56 percent tells its own story about investor conviction.
A Web of Strategic Alliances
Behind the operational momentum lies a concerted push to control more of the robotics value chain. In mid-August, at Beijing’s World Robot Conference, Ubtech signed a strategic agreement with BASiC Semiconductor covering silicon carbide power components for embodied-intelligence humanoids. The collaboration has a dual character: Ubtech’s robots will also be deployed on BASiC’s own production lines, and the partners have set a technical roadmap to evolve bus voltage from 48 volts through 96 volts toward 400 volts.
That deal sits alongside a more recent joint venture with chipmaker MetaX, established to develop and manufacture semiconductors for embodied artificial intelligence — a deeper incursion into hardware than Ubtech has previously attempted. Complementing both is a partnership with Siemens focused on digital tools for robot design and manufacturing, aimed squarely at production scalability.
The clustering of these announcements within weeks of one another signals something beyond opportunism. With a 2026 production target of 10,000 full-size humanoids, Ubtech faces acute scaling pressure. Securing chip supply and manufacturing software — at least partially in-house — reduces exposure to external suppliers at a moment when demand dynamics in the humanoid segment are shifting rapidly.
Software Ambitions and Consumer Market Entry
Ubtech is also staking a claim on the software side. Its proprietary foundation model, Thinker 1.0, reportedly tops nine leaderboards for embodied intelligence — a positioning that frames the company as an algorithm provider as much as a hardware manufacturer, an increasingly important distinction given intensifying competition from other Chinese players.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
The consumer front advances too. September marks the start of deliveries for the UWORLD-U1 companion robot series in China, for which more than 13,000 pre-orders had accumulated by end-June. Pricing spans from 119,800 yuan for the Lite version to 990,000 yuan for the Ultra variant. If the delivery schedule holds, the third quarter should capture additional revenue from this pipeline.
Governance and the Profitability Question
Corporate housekeeping has kept pace with commercial expansion. Ubtech raised its registered capital to 440 million yuan, an increase of roughly five percent, while the board deliberated in August on an employee and management share incentive programme to be settled via H-shares. An extraordinary general meeting followed in late August, complete with the customary register closure.
For all the strategic breadth — chips, software, manufacturing alliances, consumer robots and equity incentives — the share price has yet to reward the ambition. Part of the explanation lies in the broader climate for Chinese robotics equities, which has soured noticeably since a competitor’s market debut roughly two weeks ago. The sector’s valuation reset has swept up Ubtech regardless of its operational trajectory.
The central question for investors remains whether explosive humanoid revenue growth can translate into durable profitability. Media reports point to an expected EBITDA breakeven in the second half of 2026 — a milestone that, if achieved, would give the market something it has so far been unwilling to grant on promise alone.
Ad
Ubtech Robotics Stock: Buy or Sell?! New Ubtech Robotics Analysis from September 3 delivers the answer:
The latest Ubtech Robotics figures speak for themselves: Urgent action needed for Ubtech Robotics investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 3.
Ubtech Robotics: Buy or sell? Read more here...
